Regina Danielson

Regina Danielson

Company: AstraZeneca

Job title: Senior Vice President & Head of Research & Early Development

Seminars:

Panel Discussion – Could Imaging be Taken Further? Thinking Unconventionally About Diagnosis 3:30 pm

Read more

day: Day One

Disease Drivers in HFpEF – With Focus on Microvascular Inflammation 1:45 pm

Examine clinical evidence of microvascular inflammation in HFpEF Assessing molecular signatures of microvascular dysfunction in HFpEF Gain insights into clinical diagnosis of microvascular dysfunction in HFpEFRead more

day: Day One

Moderated Discussion – Understanding HFpEF 10:00 am

Are we able to define the HFpEF patient? Is HFpEF heterogeneous or is our understanding incomplete? Is there a unifying hypothesis?Read more

day: Day One

Myeloperoxidase – A Key Target Involved in the Progression of HFpEF 9:00 am

Learn how disease drivers in HFpEF are different to HFrEF Understand how MPO is linked to HFpEF severity, and involved in fibrosis, inflammation, and microvascular dysfunction Explore how inhibiting MPO has beneficial effects in patients with HFpEFRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.